AUSTIN, Texas--(BUSINESS WIRE)--WellRX, the parent company of preventative healthcare brands ReviveRX and Ways2Well, today announced it has acquired Bioreach, a state-of-the-art bloodwork and genetics laboratory. The acquisition brings advanced blood testing capabilities in-house, streamlining diagnostics and enabling the delivery of innovative health tests across WellRX’s ecosystem, including partner telehealth clinics, weight-loss programs, testosterone therapies, and regenerative medicine services. The strategic move is an expansion of WellRX’s commitment to offer a streamlined, vertically integrated approach to patients looking to optimize their overall health and wellness.
“Bioreach is a transformative addition for WellRX and its subsidiaries,” said Brigham Buhler, Founder and CEO of WellRX. “By integrating Bioreach’s cutting-edge capabilities, we’re not only accelerating bloodwork turnaround times but also unlocking deeper insights into patient health through our pharmacy and telehealth partnerships. This acquisition empowers us to drive down costs, achieve seamless vertical integration, and deliver proactive, predictive care. Together, we are reshaping healthcare to focus on healthspan—and one day, even lifespan—offering unmatched innovation, efficiency, and value to patients, clinicians, and providers. The future of medicine starts here.”
Bioreach will support clinics by enhancing patient outcomes through data-driven health solutions. Telehealth providers relying on ReviveRX for prescription services will now benefit from seamless bloodwork integration, providing comprehensive care to their patients. This advancement also expands testing services offered by Ways2Well, WellRX’s telehealth clinic specializing in preventative care and functional medicine, bringing health insights to over 50,000 patients nationwide.
A single drop of blood can measure thousands of protein, fat and metabolic molecules, helping detect metabolic and immune responses, and pave the way for early disease detection and diagnosis (Stanford). Traditionally, bloodwork results have taken five to seven business days to process. With Bioreach’s 80% improvement in testing efficiency, WellRX will cut this to just one day—a significant improvement for both patients and providers nationwide. With Bioreach, ReviveRX and Ways2Well will also continue to bring more cutting-edge tests to the market.
About Bioreach Integration:
Bioreach’s facilities will support the testing needs of clinicians, partner telehealth companies, and ReviveRX pharmacy customers. The integration of these capabilities will further ReviveRX’s commitment to providing personalized prescriptions based on robust diagnostic data.
“Our team at Bioreach has done a tremendous job educating Utah’s population on what various biomarkers in their blood can tell them about their health, so they may work in tandem with a medical professional to create a personalized wellness plan,” said Jack Matsen, CEO of Bioreach. “By joining WellRX, we’re positioned to scale affordable, high-quality blood testing services across the country. We see a bright future with expanding our impact, particularly as we integrate with ReviveRX’s patient-centric pharmacy services and Ways2Well’s innovative telehealth care.”
This acquisition is the latest in WellRX’s mission to redefine preventative healthcare.
About WellRX:
WellRX is an integrated healthcare company that bridges pharmacy services, telehealth, and preventative care. Through its subsidiaries—ReviveRX, Ways2Well, and now Bioreach—WellRX delivers seamless, patient-focused solutions for health and wellness. Note: WellRX is not affiliated with WellRx.com.
About Bioreach:
Bioreach’s mission is to extend and improve real lives, by giving ordinary people extraordinary access to their blood work and biomarkers. Bioreach is also committed to educate clients on their results, empowering them to make well-informed choices about their health, and their future.
